University of Pennsylvania-linked CNS disorder-focused drug developer Passage Bio has filed to raise up to $125m having raised $226m in funding.

The cancer therapy developer is set to raise between $140m and $160m in its initial public offering, following $226m in funding.

The UBC bioprinting spinout will use part of the funding to progress two of its projects towards commercialisation.

Utah-founded metagenomic evaluation platform developer IDbyDNA has now raised at least $29m, with the latest round to support continued commercialisation.

Retail brand reputation management business Soci has completed its series C round, having previously received series A capital from Stanford's Daper Fund.

Cloud-based audio transcription service Otter.ai won the backing of Duke University Innovation Fund and NTT Docomo Ventures in its latest round.

The University of Bristol-led incubator now has more than 80 portfolio companies, which posted a combined turnover of $77m during 2019.

University Ventures portfolio company Galvanize, which provides software engineering and data science courses, has been bought by online education platform K12 after raising $96m in funding.

Yale-founded P2 Science, which produces chemicals from clean feedstocks like vegetable oil, secured funding from investors including Elm Street Ventures to take its total to about $23.3m.

University of Washington’s François Baneyx has sealed the job of vice-provost for innovation having administered the same duties as caretaker since February last year.